Browsing Over 32 Presentations

Sort By
Welcome to ESMO Gynae 2021 and Keynote address Opening and closure session

Keynote lecture: DNA damage repair in ovarian cancer and PARP inhibitors resistance (ID 23)

Lecture Time
12:55 - 13:20
Speakers
  • A. M. Oza (Toronto, Canada, Ontario)
Session Name
Welcome to ESMO Gynae 2021 and Keynote address
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
12:45 - 13:20
Welcome to ESMO Gynae 2021 and Keynote address Opening and closure session

Live welcome (ID 21)

Lecture Time
12:45 - 12:50
Speakers
  • S. Banerjee (London, United Kingdom)
  • D. Lorusso (Rome, Italy)
  • A. Poveda Velasco (Valencia, Spain)
Session Name
Welcome to ESMO Gynae 2021 and Keynote address
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
12:45 - 13:20
Welcome to ESMO Gynae 2021 and Keynote address Opening and closure session

Introduction to the Keynote lecture (ID 22)

Lecture Time
12:50 - 12:55
Speakers
  • S. Banerjee (London, United Kingdom)
Session Name
Welcome to ESMO Gynae 2021 and Keynote address
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
12:45 - 13:20
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next? Educational session

Horizon scanning: What’s next for systemic therapy in ovarian cancer - first line and beyond? (ID 6)

Lecture Time
14:20 - 14:35
Speakers
  • D. Lorusso (Rome, Italy)
Session Name
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next?
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
13:35 - 14:50
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next? Educational session

The role of surgery for newly diagnosed ovarian cancer: Current status and future directions (ID 4)

Lecture Time
13:50 - 14:05
Speakers
  • S. Mahner (Munich, Germany)
Session Name
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next?
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
13:35 - 14:50
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next? Educational session

Live Q&A and discussion (ID 7)

Lecture Time
14:35 - 14:50
Session Name
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next?
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
13:35 - 14:50
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next? Educational session

First line maintenance therapy for ovarian cancer in 2021: What are the options? (ID 5)

Lecture Time
14:05 - 14:20
Speakers
  • I. L. Ray-Coquard (Lyon, France, CEDEX)
Session Name
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next?
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
13:35 - 14:50
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next? Educational session

The evolving role of molecular profiling for therapeutic stratification in newly diagnosed ovarian cancer (ID 3)

Lecture Time
13:35 - 13:50
Speakers
  • D. Tan (Singapore, Singapore)
Session Name
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next?
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
13:35 - 14:50
1st line maintenance strategy options for advanced ovarian cancer by HRD profile Clinical case session

Live Q&A and discussion (ID 11)

Lecture Time
16:05 - 16:20
Session Name
1st line maintenance strategy options for advanced ovarian cancer by HRD profile
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
15:05 - 16:20
1st line maintenance strategy options for advanced ovarian cancer by HRD profile Clinical case session

Clinical case - What options for HR proficient patients? Criteria for treatment choice (ID 9)

Lecture Time
15:25 - 15:45
Speakers
  • N. Colombo (Milan, Italy)
Session Name
1st line maintenance strategy options for advanced ovarian cancer by HRD profile
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
15:05 - 16:20
1st line maintenance strategy options for advanced ovarian cancer by HRD profile Clinical case session

Clinical case - Combination vs sequence: Clinical implications (ID 10)

Lecture Time
15:45 - 16:05
Speakers
  • S. Lheureux (Toronto, Canada, Ontario)
Session Name
1st line maintenance strategy options for advanced ovarian cancer by HRD profile
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
15:05 - 16:20
1st line maintenance strategy options for advanced ovarian cancer by HRD profile Clinical case session

Clinical case - What options for HRD patients? Criteria for treatment choice (ID 8)

Lecture Time
15:05 - 15:25
Speakers
  • E. C. Kohn (Bethesda, United States of America)
Session Name
1st line maintenance strategy options for advanced ovarian cancer by HRD profile
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
15:05 - 16:20